Sema4 to lay off about 250 people, close Branford laboratory
The genomic-testing specialist Sema4 is making big changes that include the elimination of about 250 jobs and the closing of its laboratory in Branford.
Stay updated with breaking news from Eric Schadt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The genomic-testing specialist Sema4 is making big changes that include the elimination of about 250 jobs and the closing of its laboratory in Branford.
The healthcare company delivered plenty of bad news in its Q2 update.
Sema4 Holdings Corp., a publicly traded health information company based in Stamford, said it plans to eliminate about 250 positions, roughly 13% of its workforce. The restructuring was announced Monday as part of Sema4’s second quarter financial results. The company has eliminated about 30% of its positions, including layoffs that occurred during the first half of the year. Sema4 plans to move its hereditary cancer testing operations from Stamford to Gaithersburg, Maryland at the end of the third quarter, according to the announcement.
The layoffs represent 13% of the AI-backed genomic and clinical data company's workforce.
Investment analysts at The Goldman Sachs Group began coverage on shares of Sema4 (NASDAQ:SMFR – Get Rating) in a research report issued on Thursday, The Fly reports. The firm set a “buy” rating on the stock. A number of other equities analysts have also recently issued reports on SMFR. Compass Point decreased their price objective […]